Table 1.
Comparisons of ChIP, DamID, ChEC, and CUT&Tag
| Aspect of the method | ChIP | DamID | ChEC | CUT&Tag |
|---|---|---|---|---|
| Principle | Antibody used to precipitate protein of interest with the DNA it is bound to, which is resolved by DNA-seq. | Fused DNA-binding protein with DAM methylates adenines at binding sites, detected via sequencing. | Uses MNase-fused DNA-binding protein to cleave chromatin at DNA-binding sites. | Uses protein specific antibodies in conjunction with Tn5 transposase to tag and sequence protein-bound DNA. |
| Strengths | Genome-wide mapping of protein–DNA interactions with high resolution. Well-established, standardized protocols and widely supported bioinformatic pipelines. | Direct mapping of protein–DNA interactions within cells. No cross-linking required; avoiding artifacts. Does not require the use of antibodies. |
Produces robust data when used in conjunction with DoubleChEC. Captures transient interactions. Does not require cross-linking; avoiding artifacts. | High-resolution mapping. Works effectively with a relatively small number of cells. Reduced sequencing depth compared with other immunotethering-based methods. |
| Limitations | Relies on the presence of highly specific antibodies. Requires cross-linking, which can cause artifacts. Will not capture transient interactions. Antibody binding can skew the results. | Limited by chromatin structure. Can produce unintended methylation, leading to background signals. Requires introduction of fusion protein, which is not at a physiological level. | Less suitable for work on highly abundant proteins. Requires cell permeabilization. Requires introduction of fusion protein, which is not at a physiological level. | Relies on the presence of highly specific antibodies. Nonspecific noise may be caused by mitochondrial DNA. Potential for missing data related to low-affinity DNA-binding proteins. |
| Specificity | As specific as the antibody. | Moderately specific; potential for bias owing to the preferential methylation of adenine in specific sequence contexts. | Highly specific for protein binding sites, enhanced by the ability to control activation of MNase. | As specific as the antibody. |
